| Substance | Condition | Seq | Src | PMID | Dtl | Title |
| Dihydroartemisinin | Bone Cancer | 1 | PM | 37056396 | 📋 | Dihydroartemisinin Potentiates VEGFR-TKIs Antitumorigenic Effect on Osteosarcoma by Regulating Loxl2/VEGFA Expression and Lipid Metabolism Pathway |
| Dihydroartemisinin | Bone Formation | 1 | PM | 31534957 | 📋 | Dihydroartemisinin Promotes the Osteogenesis of Human Mesenchymal Stem Cells via the ERK and Wnt/ β-Catenin Signaling Pathways |
| Dihydroartemisinin | Bone Fractures | 1 | PM | 31534957 | 📋 | Dihydroartemisinin Promotes the Osteogenesis of Human Mesenchymal Stem Cells via the ERK and Wnt/ β-Catenin Signaling Pathways |
| Dihydroartemisinin | Degenerative Disk Disease | 1 | PM | 36120596 | 📋 | Dihydroartemisinin Attenuated Intervertebral Disc Degeneration via Inhibiting PI3K/AKT and NF- κ B Signaling Pathways |
| Dihydroartemisinin | Osteoarthritis | 1 | PM | 34738623 | 📋 | Dihydroartemisinin attenuates osteoclast formation and bone resorption via inhibiting the NF‑κB, MAPK and NFATc1 signaling pathways and alleviates osteoarthritis |
| Dihydroartemisinin | Rheumatoid Arthritis | 1 | PM | 38447418 | 📋 | Dihydroartemisinin alleviates erosive bone destruction by modifying local Treg cells in inflamed joints: A novel role in the treatment of rheumatoid arthritis |
